Supernus Pharmaceuticals (SUPN) Current Deferred Tax Assets (2015)
Supernus Pharmaceuticals (SUPN) posted quarterly Current Deferred Tax Assets of -$200000.0 for Q4 2015.
Supernus Pharmaceuticals (SUPN) Current Deferred Tax Assets (2015) Analysis & Trends
Supernus Pharmaceuticals has reported Current Deferred Tax Assets for 1 years, with the latest figure at -$200000.0 in Q4 2015.
- Current Deferred Tax Assets for Q4 2015 came in at -$200000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was -$200000.0 (changed N/A YoY), and the FY2015 annual result was -$200000.0, changed N/A from the prior year.
- Current Deferred Tax Assets was little changed at -$200000.0 in Q4 2015.
- Over five years, Current Deferred Tax Assets peaked at -$200000.0 in Q4 2015 and troughed at -$200000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -200,000.00 |
| Dec 31, 2015 | -200,000.00 |